Ozempic 0.25-0.5 MG/dose pen 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F7UZ4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,863
Award facts
- Contract value 100% obligated
- $21,862.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,862.86 delivery order to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pens (3ml) on January 8, 2026, with completion scheduled for January 9, 2026. This contract utilizes a firm fixed-price structure with no set-aside designation, indicating competitive award based on open competition. The award is executed at AmerisourceBergen Drug Corp's Conshohocken, Pennsylvania facility, where the parent company Cencora, Inc. (doing business as AmerisourceBergen) maintains its corporate headquarters. This delivery order represents a specific task issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026.
AmerisourceBergen serves as a critical pharmaceutical distributor for the Defense Logistics Agency's medical supply chain, fulfilling requirements across military healthcare systems and supporting military treatment facilities worldwide. The company's extensive contract portfolio with DLA encompasses a comprehensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This particular delivery order for Ozempic, a diabetes management medication, reflects the ongoing federal procurement of essential prescription pharmaceuticals to support military medical operations and beneficiary care.
Quick answers
Who was awarded contract SPE2DR26F7UZ4?
SPE2DR26F7UZ4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26F7UZ4 worth?
The government has obligated $21,863 on SPE2DR26F7UZ4.
Is contract SPE2DR26F7UZ4 an order under another contract?
Yes. SPE2DR26F7UZ4 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7UZ4 competed?
The extent of competition for SPE2DR26F7UZ4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award